Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	133.08	117.27	91.3	57.97	55.15	53.19
Other Revenue	-	-	-	-	0.12	0.15
Revenue	133.08	117.27	91.3	57.97	55.26	53.34
Revenue Growth (YoY)	16.88%	28.44%	57.50%	4.90%	3.61%	-17.54%
Cost of Revenue	50.54	49.05	35.84	25.83	22.77	18.95
Gross Profit	82.54	68.22	55.47	32.14	32.49	34.39
Selling, General & Admin	74.03	77.91	64.29	37.98	34.87	34.49
Research & Development	2.17	2.39	1.34	0.92	0.87	0.66
Operating Expenses	76.2	80.29	65.63	38.89	35.74	35.14
Operating Income	6.35	-12.07	-10.16	-6.76	-3.25	-0.75
Interest Expense	-4.09	-4.16	-2.94	-1.69	-1	-5.98
Interest & Investment Income	-	-	0.15	0.03	-	-
Currency Exchange Gain (Loss)	0.05	0.01	0.27	-	-	-
Other Non Operating Income (Expenses)	-0.05	-0.03	-0.05	-	-	-
EBT Excluding Unusual Items	2.26	-16.26	-12.73	-8.42	-4.25	-6.73
Legal Settlements	-	-	-	-	-0.6	-
Other Unusual Items	-	-	11.69	-	-	-
Pretax Income	2.26	-16.26	-1.04	-8.42	-4.85	-6.73
Income Tax Expense	0.51	0.19	-1.7	0.07	-	0.3
Net Income	1.75	-16.45	0.66	-8.49	-4.85	-7.02
Net Income to Common	1.75	-16.45	0.66	-8.49	-4.85	-7.02
Shares Outstanding (Basic)	139	134	119	94	85	28
Shares Outstanding (Diluted)	147	134	127	94	85	28
Shares Change (YoY)	11.96%	5.42%	34.76%	10.10%	199.85%	116.50%
EPS (Basic)	0.01	-0.12	0.01	-0.09	-0.06	-0.25
EPS (Diluted)	0.01	-0.12	0.01	-0.09	-0.06	-0.25
Free Cash Flow	5.17	-16.01	-10.97	-7.11	-1.68	-2.28
Free Cash Flow Per Share	0.04	-0.12	-0.09	-0.08	-0.02	-0.08
Gross Margin	62.02%	58.17%	60.75%	55.44%	58.79%	64.48%
Operating Margin	4.77%	-10.30%	-11.13%	-11.65%	-5.89%	-1.41%
Profit Margin	1.32%	-14.03%	0.72%	-14.64%	-8.77%	-13.17%
Free Cash Flow Margin	3.89%	-13.65%	-12.02%	-12.26%	-3.03%	-4.27%
EBITDA	10.9	-7.85	-6.98	-5.46	-1.92	1.33
EBITDA Margin	8.19%	-6.69%	-7.65%	-9.42%	-3.48%	2.49%
D&A For EBITDA	4.55	4.22	3.17	1.29	1.33	2.08
EBIT	6.35	-12.07	-10.16	-6.76	-3.25	-0.75
EBIT Margin	4.77%	-10.30%	-11.13%	-11.65%	-5.89%	-1.41%
Revenue as Reported	133.08	117.27	91.3	-	55.26	53.34

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q